Description
A test aimed at determining the free beta-subunit of human chorionic gonadotropin in order to identify the risk of fetal chromosomal abnormalities, trophoblastic diseases and neoplasms, testicular tumors, and tumors of other localizations.
Period of execution
Within 3 days. The specified time does not include the day of biomaterial collection
Biomaterial type